Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age.

Obando-Pacheco P, Rivero-Calle I, Raguindin PF, Martinón-Torres F.

Expert Rev Vaccines. 2019 Nov 7. doi: 10.1080/14760584.2019.1690457. [Epub ahead of print]

PMID:
31697185
2.

Bacteremia in Childhood Life-Threatening Infections in Urban Gambia: EUCLIDS in West Africa.

Secka F, Herberg JA, Sarr I, Darboe S, Sey G, Saidykhan M, Wathuo M, Kaforou M, Antonio M, Roca A, Zaman SMA, Cebey-López M, Boeddha NP, Paulus S, Kohlfürst DS, Emonts M, Zenz W, Carrol ED, de Groot R, Schlapbach L, Martinon-Torres F, Bojang K, Levin M, van der Flier M, Anderson ST.

Open Forum Infect Dis. 2019 Jul 27;6(9):ofz332. doi: 10.1093/ofid/ofz332. eCollection 2019 Sep.

3.

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B.

Rivero-Calle I, Raguindin PF, Gómez-Rial J, Rodriguez-Tenreiro C, Martinón-Torres F.

Infect Drug Resist. 2019 Oct 9;12:3169-3188. doi: 10.2147/IDR.S159952. eCollection 2019.

4.

Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe-wide trials.

Ruggieri L, Bonifazi D, Landi A, Bonifazi F, Bartoloni F, Costello M, Felisi MG, Gasthuys E, Godo A, Martinon Torres F, Nadal D, Nuytinck L, Rocchi F, Turner M, Ceci A.

Acta Paediatr. 2019 Sep 18. doi: 10.1111/apa.15020. [Epub ahead of print]

PMID:
31532836
5.

The challenges of influenza for public health.

Álvarez F, Froes F, Rojas AG, Moreno-Perez D, Martinón-Torres F.

Future Microbiol. 2019 Sep 9. doi: 10.2217/fmb-2019-0203. [Epub ahead of print]

PMID:
31498705
6.

A qPCR expression assay of IFI44L gene differentiates viral from bacterial infections in febrile children.

Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Barral-Arca R, Rivero-Calle I, Pischedda S, Currás-Tuala MJ, Gómez-Rial J, Barros F, Martinón-Torres F, Salas A.

Sci Rep. 2019 Aug 13;9(1):11780. doi: 10.1038/s41598-019-48162-9.

7.

Meningococcal disease: Can we predict the unpredictable?

Martinón-Torres F, Trilla A.

Med Clin (Barc). 2019 Jul 23. pii: S0025-7753(19)30413-0. doi: 10.1016/j.medcli.2019.04.035. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31350058
8.

Diversity in the emergency care for febrile children in Europe: a questionnaire study.

Borensztajn D, Yeung S, Hagedoorn NN, Balode A, von Both U, Carrol ED, Dewez JE, Eleftheriou I, Emonts M, van der Flier M, de Groot R, Herberg JA, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Nijman R, Pokorn M, Strle F, Tsolia M, Wendelin G, Zavadska D, Zenz W, Levin M, Moll HA.

BMJ Paediatr Open. 2019 Jun 27;3(1):e000456. doi: 10.1136/bmjpo-2019-000456. eCollection 2019.

9.

Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial.

Safadi MAP, Martinon-Torres F, Weckx LY, Moreira ED Junior, da Fonseca Lima EJ, Willemsen A, Toneatto D, Habib MA, Borys D.

Vaccine. 2019 Aug 14;37(35):4858-4863. doi: 10.1016/j.vaccine.2019.07.021. Epub 2019 Jul 18.

10.

Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine.

Danier J, Rivera L, Claeys C, Dbaibo G, Jain VK, Kosalaraksa P, Woo W, Yanni E, Zaman K, Acosta B, Amanullah A, Ariza M, Luisa Arroba Basanta M, Bavdekar A, Carmona A, Cousin L, Diaz A, Diez-Domingo J, Cagri Dinleyici E, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Antionette Gonzales L, Hacimustafaoglu M, Hughes SM, Izu A, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martinón-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Soni J, Szymanski H, Ulied A, Schuind A, Innis BL; Flu4VEC Study Group.

Pediatr Infect Dis J. 2019 Aug;38(8):866-872. doi: 10.1097/INF.0000000000002387.

PMID:
31306399
11.

False Vaccine Contraindications Among Healthcare Providers in Europe: A Short Survey Among Members of The European Society of Pediatric Infectious Diseases.

Rivero I, Raguindin PF, Buttler R, Martinon-Torres F.

Pediatr Infect Dis J. 2019 Sep;38(9):974-976. doi: 10.1097/INF.0000000000002401.

PMID:
31261366
12.

Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults.

Martinón-Torres F, Nolan T, Toneatto D, Banzhoff A.

Hum Vaccin Immunother. 2019 Jul 9:1-12. doi: 10.1080/21645515.2019.1627159. [Epub ahead of print]

PMID:
31246520
13.

The ReSVinet Score for Bronchiolitis: A Scale for All Seasons.

Justicia-Grande AJ, Martinón-Torres F.

Am J Perinatol. 2019 Jul;36(S 02):S48-S53. doi: 10.1055/s-0039-1691800. Epub 2019 Jun 25.

PMID:
31238359
14.

OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.

Cotugno N, Ruggiero A, Santilli V, Manno EC, Rocca S, Zicari S, Amodio D, Colucci M, Rossi P, Levy O, Martinon-Torres F, Pollard AJ, Palma P.

J Immunol Res. 2019 Apr 28;2019:8732191. doi: 10.1155/2019/8732191. eCollection 2019. Review.

15.

Lifestyle and comorbid conditions as risk factors for community-acquired pneumonia in outpatient adults (NEUMO-ES-RISK project).

Rivero-Calle I, Cebey-López M, Pardo-Seco J, Yuste J, Redondo E, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares-Rufo M, Jimeno I, Gil A, Molina J, Ocaña D, Martinón-Torres F.

BMJ Open Respir Res. 2019 Mar 12;6(1):e000359. doi: 10.1136/bmjresp-2018-000359. eCollection 2019.

16.

TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines.

Martinón-Torres F, Bosch X, Rappuoli R, Ladhani S, Redondo E, Vesikari T, García-Sastre A, Rivero-Calle I, Gómez-Rial J, Salas A, Martín C, Finn A, Butler R.

Hum Vaccin Immunother. 2019;15(10):2405-2415. doi: 10.1080/21645515.2019.1609823. Epub 2019 Jun 3.

17.

[From a pathogen's genome to an effective vaccine: the four-component meningococcal serogroup B vaccine].

Abad R, Martinón-Torres F, Santolaya ME, Banzhoff A, González-Inchausti C, Graña MG, Vázquez JA.

Rev Esp Quimioter. 2019 Jun;32(3):208-216. Epub 2019 May 30. Review. Spanish.

18.

Further considerations on rotavirus vaccination and seizure-related hospitalization rates.

Gómez-Rial J, Sánchez-Batán S, Rivero-Calle I, Pardo-Seco J, Martinón-Martínez JM, Salas A, Martinón-Torres F.

Infect Drug Resist. 2019 Apr 29;12:989-991. doi: 10.2147/IDR.S208756. eCollection 2019. No abstract available.

19.

The challenge of the laboratory diagnosis in a confirmed congenital Zika virus syndrome in utero: A case report.

Sulleiro E, Frick MA, Rodó C, Espasa M, Thorne C, Espiau M, Martín-Nalda A, Suy A, Giaquinto C, Melendo S, Rando A, Alarcón A, Martinón-Torres F, Pumarola T, Soler-Palacín P, Soriano-Arandes A.

Medicine (Baltimore). 2019 May;98(20):e15532. doi: 10.1097/MD.0000000000015532.

20.

Impact of rotavirus vaccination on childhood hospitalizations for seizures: Heterologous or unforeseen direct vaccine effects?

Salas A, Pardo-Seco J, Cebey-López M, Martinón-Martínez JM, Gómez-Rial J, Currás-Tuala MJ, Pischedda S, Barral-Arca R, Justicia-Grande A, Rivero-Calle I, Vilar J, Martinón-Torres F.

Vaccine. 2019 May 31;37(25):3362-3368. doi: 10.1016/j.vaccine.2019.04.086. Epub 2019 May 4.

PMID:
31064673
21.

Identification of regulatory variants associated with genetic susceptibility to meningococcal disease.

Borghini L, Png E, Binder A, Wright VJ, Pinnock E, de Groot R, Hazelzet J, Emonts M, Van der Flier M, Schlapbach LJ, Anderson S, Secka F, Salas A, Fink C, Carrol ED, Pollard AJ, Coin LJ, Kuijpers TW, Martinon-Torres F, Zenz W, Levin M, Hibberd ML, Davila S; EUCLIDS consortium.

Sci Rep. 2019 May 6;9(1):6966. doi: 10.1038/s41598-019-43292-6.

22.

Ancestry patterns inferred from massive RNA-seq data.

Barral-Arca R, Pardo-Seco J, Bello X, Martinón-Torres F, Salas A.

RNA. 2019 Jul;25(7):857-868. doi: 10.1261/rna.070052.118. Epub 2019 Apr 22.

PMID:
31010885
23.

[What have we learnt about rotavirus in Spain in the last 10 years?]

Díez-Domingo J, Garcés-Sánchez M, Giménez-Sánchez F, Colomina-Rodríguez J, Martinón-Torres F.

An Pediatr (Barc). 2019 Sep;91(3):166-179. doi: 10.1016/j.anpedi.2019.01.024. Epub 2019 Apr 7. Spanish.

24.

[The new official vaccine calendar for adults does not include the prevention of pneumococcal pneumonia].

Redondo E, Rivero-Calle I, Mascarós E, Díaz-Maroto JL, Linares M, Gil A, Molina J, Jimeno I, Ocaña D, Yuste JE, Martinón-Torres F; Grupo de Neumoexpertos en Prevención.

Rev Esp Quimioter. 2019 Jun;32(3):281-283. Epub 2019 Mar 26. Spanish.

25.

Safety and immunogenicity of pneumococcal conjugate vaccines in preterm infants.

López-Sanguos C, Rivero Calle I, Rodriguez Tenreiro C, Raguindin PF, Martinón-Torres F.

Expert Opin Drug Saf. 2019 Apr;18(4):253-259. doi: 10.1080/14740338.2019.1597849. Epub 2019 Apr 4. Review.

PMID:
30907170
26.

Rotavirus infection beyond the gut.

Gómez-Rial J, Sánchez-Batán S, Rivero-Calle I, Pardo-Seco J, Martinón-Martínez JM, Salas A, Martinón-Torres F.

Infect Drug Resist. 2018 Dec 24;12:55-64. doi: 10.2147/IDR.S186404. eCollection 2019. Review.

27.

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.

Pepin S, Dupuy M, Borja-Tabora CFC, Montellano M, Bravo L, Santos J, de Castro JA, Rivera-Medina DM, Cutland C, Ariza M, Diez-Domingo J, Gonzalez CD, Martinón-Torres F, Papadopoulou-Alataki E, Theodoriadou M, Kazek-Duret MP, Gurunathan S, De Bruijn I; GQM05 Study Group.

Vaccine. 2019 Mar 22;37(13):1876-1884. doi: 10.1016/j.vaccine.2018.11.074. Epub 2018 Dec 14.

28.

[Description of Influenza B in seasonal epidemics in Spain].

Ortiz de Lejarazu R, Díez Domingo J, Gil de Miguel A, Martinón Torres F, Guzmán Quilo C, Guillén JM, Piedrafita B, Redondo Marguello E.

Rev Esp Quimioter. 2018 Dec;31(6):511-519. Epub 2018 Nov 5. Spanish.

29.

Implementing Universal Varicella Vaccination in Europe: The Path Forward.

Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, Vesikari T.

Pediatr Infect Dis J. 2019 Feb;38(2):181-188. doi: 10.1097/INF.0000000000002233.

PMID:
30408002
30.

Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers.

Martinón-Torres F, Diez-Domingo J, Feroldi E, Jordanov E, B'Chir S, Da Costa X.

Pediatr Infect Dis J. 2019 Mar;38(3):317-322. doi: 10.1097/INF.0000000000002231.

PMID:
30408001
31.

Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children.

Claeys C, Chandrasekaran V, García-Sicilia J, Prymula R, Díez-Domingo J, Brzostek J, Marès-Bermúdez J, Martinón-Torres F, Pollard AJ, Růžková R, Carmona Martinez A, Ulied A, Miranda Valdivieso M, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK.

Pediatr Infect Dis J. 2019 Feb;38(2):203-210. doi: 10.1097/INF.0000000000002217.

32.

[Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].

Redondo E, Rivero-Calle I, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares M, Gil A, Molina J, Jimeno I, Ocaña D, Yuste JE, Martinón-Torres F; en nombre de Neumoexpertos en Prevención.

Semergen. 2018 Nov - Dec;44(8):590-597. doi: 10.1016/j.semerg.2018.09.005. Epub 2018 Oct 11. Review. Spanish.

PMID:
30318406
33.

[Paediatric research in Spain: Challenges and priorities. INVEST-AEP Platform].

Calvo C, Sainz T, Codoñer-Franch P, Santiago B, García-García ML, García Vera C, Muñoz-Fernandez MA, Pérez-Martínez A, Rivero I, Fernandez Pérez C, Mejías A, Martinón-Torres F, Cabañas F.

An Pediatr (Barc). 2018 Nov;89(5):314.e1-314.e6. doi: 10.1016/j.anpedi.2018.09.001. Epub 2018 Oct 9. Spanish.

34.

Priority Needs for Conducting Pandemic-relevant Clinical Research With Children in Europe: A Consensus Study With Pediatric Clinician-researchers.

Gal M, Gobat N, Francis NA, Hood K, Butler CC, Bielicki J, Fraaij PL, Sharland M, Jarvis J, van Rossum AMC, Heikkinen T, Martinon-Torres F, Herberg J, Watkins A, Webb SAR, Moore R, Sukumar P, Nichol A.

Pediatr Infect Dis J. 2019 May;38(5):e82-e86. doi: 10.1097/INF.0000000000002204.

35.

Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study.

Martinón-Torres F, Salas A, Rivero-Calle I, Cebey-López M, Pardo-Seco J, Herberg JA, Boeddha NP, Klobassa DS, Secka F, Paulus S, de Groot R, Schlapbach LJ, Driessen GJ, Anderson ST, Emonts M, Zenz W, Carrol ED, Van der Flier M, Levin M; EUCLIDS Consortium.

Lancet Child Adolesc Health. 2018 Jun;2(6):404-414. doi: 10.1016/S2352-4642(18)30113-5. Epub 2018 Apr 28.

36.

Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons.

Claeys C, Zaman K, Dbaibo G, Li P, Izu A, Kosalaraksa P, Rivera L, Acosta B, Arroba Basanta ML, Aziz A, Cabanero MA, Chandrashekaran V, Corsaro B, Cousin L, Diaz A, Diez-Domingo J, Dinleyici EC, Faust SN, Friel D, Garcia-Sicilia J, Gomez-Go GD, Antoinette Gonzales ML, Hughes SM, Jackowska T, Kant S, Lucero M, Malvaux L, Mares Bermudez J, Martinon-Torres F, Miranda M, Montellano M, Peix Sambola MA, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Salamanca de la Cueva I, Sokal E, Soni J, Szymanski H, Ulied A, Schuind A, Jain VK, Innis BL; Flu4VEC Study Group.

Lancet Child Adolesc Health. 2018 May;2(5):338-349. doi: 10.1016/S2352-4642(18)30062-2. Epub 2018 Mar 5.

PMID:
30169267
37.

Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function.

Martinón-Torres F, Bernatowska E, Shcherbina A, Esposito S, Szenborn L, Marti MC, Hughes S, Faust SN, Gonzalez-Granado LI, Yu LM, D'Agostino D, Calabresi M, Toneatto D, Snape MD.

Pediatrics. 2018 Sep;142(3). pii: e20174250. doi: 10.1542/peds.2017-4250. Epub 2018 Aug 1. Erratum in: Pediatrics. 2019 Mar;143(3):.

38.

Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol.

Bongard E, van der Velden AW, Cook J, Saville B, Beutels P, Munck Aabenhus R, Brugman C, Chlabicz S, Coenen S, Colliers A, Davies M, De Paor M, De Sutter A, Francis NA, Glinz D, Godycki-Ćwirko M, Goossens H, Holmes J, Ieven M, de Jong M, Lindbaek M, Little P, Martinón-Torres F, Moragas A, Pauer J, Pfeiferová M, Radzeviciene-Jurgute R, Sundvall PD, Torres A, Touboul P, Varthalis D, Verheij T, Butler CC.

BMJ Open. 2018 Jul 12;8(7):e021032. doi: 10.1136/bmjopen-2017-021032.

39.

Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS).

Boeddha NP, Schlapbach LJ, Driessen GJ, Herberg JA, Rivero-Calle I, Cebey-López M, Klobassa DS, Philipsen R, de Groot R, Inwald DP, Nadel S, Paulus S, Pinnock E, Secka F, Anderson ST, Agbeko RS, Berger C, Fink CG, Carrol ED, Zenz W, Levin M, van der Flier M, Martinón-Torres F, Hazelzet JA, Emonts M; EUCLIDS consortium.

Crit Care. 2018 May 31;22(1):143. doi: 10.1186/s13054-018-2052-7.

40.

A 2-transcript host cell signature distinguishes viral from bacterial diarrhea and it is influenced by the severity of symptoms.

Barral-Arca R, Pardo-Seco J, Martinón-Torres F, Salas A.

Sci Rep. 2018 May 23;8(1):8043. doi: 10.1038/s41598-018-26239-1.

41.

Whole Exome Sequencing Identifies New Host Genomic Susceptibility Factors in Empyema Caused by Streptococcus pneumoniae in Children: A Pilot Study.

Salas A, Pardo-Seco J, Barral-Arca R, Cebey-López M, Gómez-Carballa A, Rivero-Calle I, Pischedda S, Currás-Tuala MJ, Amigo J, Gómez-Rial J, Martinón-Torres F; GENDRES Network.

Genes (Basel). 2018 May 3;9(5). pii: E240. doi: 10.3390/genes9050240.

42.

The peopling of South America and the trans-Andean gene flow of the first settlers.

Gómez-Carballa A, Pardo-Seco J, Brandini S, Achilli A, Perego UA, Coble MD, Diegoli TM, Álvarez-Iglesias V, Martinón-Torres F, Olivieri A, Torroni A, Salas A.

Genome Res. 2018 Jun;28(6):767-779. doi: 10.1101/gr.234674.118. Epub 2018 May 7.

43.

Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.

Claeys C, Drame M, García-Sicilia J, Zaman K, Carmona A, Tran PM, Miranda M, Martinón-Torres F, Thollot F, Horn M, Schwarz TF, Behre U, Merino JM, Sadowska-Krawczenko I, Szymański H, Schu P, Neumeier E, Li P, Jain VK, Innis BL.

BMC Infect Dis. 2018 Apr 18;18(1):186. doi: 10.1186/s12879-018-3079-8.

44.

Rotavirus intestinal infection induces an oral mucosa cytokine response.

Gómez-Rial J, Curras-Tuala MJ, Rivero-Calle I, Rodríguez-Tenreiro C, Redondo-Collazo L, Gómez-Carballa A, Pardo-Seco J, Salas A, Martinón-Torres F.

PLoS One. 2018 Apr 5;13(4):e0195314. doi: 10.1371/journal.pone.0195314. eCollection 2018.

45.

Controlling pertussis: how can we do it? A focus on immunization.

Martinón-Torres F, Heininger U, Thomson A, Wirsing von König CH.

Expert Rev Vaccines. 2018 Apr;17(4):289-297. doi: 10.1080/14760584.2018.1445530. Epub 2018 Mar 12. Review.

PMID:
29482390
46.

What we know and what we don't know about perinatal Zika virus infection: a systematic review.

Soriano-Arandes A, Rivero-Calle I, Nastouli E, Espiau M, Frick MA, Alarcon A, Martinón-Torres F.

Expert Rev Anti Infect Ther. 2018 Mar;16(3):243-254. doi: 10.1080/14787210.2018.1438265. Epub 2018 Feb 15. Review.

PMID:
29415586
47.

Respiratory Syncytial Virus Seasonality: A Global Overview.

Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodríguez-Tenreiro C, Sly P, Ramilo O, Mejías A, Baraldi E, Papadopoulos NG, Nair H, Nunes MC, Kragten-Tabatabaie L, Heikkinen T, Greenough A, Stein RT, Manzoni P, Bont L, Martinón-Torres F.

J Infect Dis. 2018 Apr 11;217(9):1356-1364. doi: 10.1093/infdis/jiy056. Review.

PMID:
29390105
48.

The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta-analysis.

Chan M, Park JJ, Shi T, Martinón-Torres F, Bont L, Nair H; Respiratory Syncytial Virus Network (ReSViNET).

J Glob Health. 2017 Dec;7(2):020413. doi: 10.7189/jogh.07.020413. Review.

49.

Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial.

Martinón-Torres F, Carmona Martinez A, Simkó R, Infante Marquez P, Arimany JL, Gimenez-Sanchez F, Couceiro Gianzo JA, Kovács É, Rojo P, Wang H, Bhusal C, Toneatto D.

J Infect. 2018 Mar;76(3):258-269. doi: 10.1016/j.jinf.2017.12.005. Epub 2017 Dec 15.

50.

Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC).

de Hoog MLA, Vesikari T, Giaquinto C, Huppertz HI, Martinon-Torres F, Bruijning-Verhagen P.

Hum Vaccin Immunother. 2018 Apr 3;14(4):1027-1034. doi: 10.1080/21645515.2017.1412019. Epub 2018 Jan 18.

Supplemental Content

Loading ...
Support Center